Back
Climb Global Solutions Vs. Novo Nordisk AS Industry Stock Comparison
Buy
57
CLMB
Climb Global Solutions
Last Price:
$123.59
Seasonality Move:
9.27%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$85.80
Seasonality Move:
9.09%
Buy
57
Climb Global Solutions (CLMB)
is a Buy
Is Climb Global Solutions a Buy, Sell or Hold?
-
The current Climb Global Solutions [CLMB] share price is $124.25. The Score for CLMB is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
CLMB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $85.80. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CLMB Stock Price Chart
What is Climb Global Solutions's stock price today?
-
The Climb Global Solutions share price today is $124.25The current trend is moderately bearish and CLMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
CLMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 45.28 | Sell |
Chaikin Money Flow: | 22986 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.24 - 132.64) | Sell |
Bollinger Bands (100): | (94.28 - 128.02) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.96 | Sell |
Relative Strength Index (14 RSI): | 34.17 | Sell |
Chaikin Money Flow: | -8539 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.39 - 108.31) | Sell |
Bollinger Bands (100): | (98.73 - 129.07) | Sell |
CLMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.71 | Sell |
20-day SMA: | 127.09 | Sell |
50-day SMA: | 125.87 | Sell |
200-day SMA: | 87.35 | Buy |
8-day EMA: | 125.49 | Sell |
20-day EMA: | 126.76 | Sell |
50-day EMA: | 122.99 | Buy |
200-day EMA: | 94.94 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.56 | Buy |
20-day SMA: | 93.7 | Sell |
50-day SMA: | 101.86 | Sell |
200-day SMA: | 123.41 | Sell |
8-day EMA: | 86.3 | Sell |
20-day EMA: | 91.8 | Sell |
50-day EMA: | 100.89 | Sell |
200-day EMA: | 114.41 | Sell |
Climb Global Solutions Earnings Growth & CLMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Climb Global Solutions Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |